VideoBites

Videobite: Contract Pharma Sits Down with Peter Surman of Douglas CDMO

Chief Science Officer, Peter Surman, shares insight on why pharmaceutical companies should consider softgels for their next oral dosage form.

Company Logo

Released By Douglas CDMO

Learn more at https://www.douglascdmo.com/

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Request more information from Douglas CDMO